Nickson Philip
Insider CIK 1911369 · GLUE General Counsel
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| GLUE Monte Rosa Therapeutics, I | S Sale | 2026-04-09 | 2026-04-10 | 5,845 | $17.69 | $103.4K | 55,000 | SEC↗ |
| GLUE Monte Rosa Therapeutics, I | S Sale | 2026-01-05 | 2026-01-05 | 3,155 | $15.17 | $47.9K | 60,845 | SEC↗ |
| GLUE Monte Rosa Therapeutics, I | A Award deriv | 2026-01-02 | 2026-01-05 | 126,000 | — | $0 | 126,000 | SEC↗ |
| GLUE Monte Rosa Therapeutics, I | A Award | 2026-01-02 | 2026-01-05 | 28,000 | — | $0 | 64,000 | SEC↗ |
| GLUE Monte Rosa Therapeutics, I | A Award deriv | 2025-01-02 | 2025-01-06 | 161,000 | — | $0 | 161,000 | SEC↗ |
| GLUE Monte Rosa Therapeutics, I | A Award | 2025-01-02 | 2025-01-06 | 36,000 | — | $0 | 36,000 | SEC↗ |
| GLUE Monte Rosa Therapeutics, I | A Award deriv | 2024-06-03 | 2024-06-05 | 40,000 | — | $0 | 40,000 | SEC↗ |
| GLUE Monte Rosa Therapeutics, I | A Award deriv | 2024-01-02 | 2024-01-04 | 109,000 | — | $0 | 109,000 | SEC↗ |
| GLUE Monte Rosa Therapeutics, I | A Award deriv | 2023-01-03 | 2023-01-04 | 123,650 | — | $0 | 123,650 | SEC↗ |
| GLUE Monte Rosa Therapeutics, I | A Award deriv | 2022-03-01 | 2022-03-02 | 70,600 | — | $0 | 70,600 | SEC↗ |